Publikationen in Zusammenarbeit mit Forschern von Icahn School of Medicine at Mount Sinai (9)

2024

  1. Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysis

    Journal of Hepatology

2022

  1. Unannotated small RNA clusters associated with circulating extracellular vesicles detect early stage liver cancer

    Gut, Vol. 71, Núm. 10, pp. 2069-2080

2020

  1. Intratumoral heterogeneity and clonal evolution in liver cancer

    Nature Communications, Vol. 11, Núm. 1

2019

  1. A phenotypical map of disseminated hepatocellular carcinoma suggests clonal constraints in metastatic sites

    Histopathology, Vol. 74, Núm. 5, pp. 718-730

2018

  1. A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma

    Oncogene, Vol. 37, Núm. 27, pp. 3740-3752

  2. High-density single cell mRNA sequencing to characterize circulating tumor cells in hepatocellular carcinoma

    Scientific Reports, Vol. 8, Núm. 1

2017

  1. Modulating Immune Responses to Overcome Resistance in Hepatocellular Carcinoma

    RESISTANCE TO MOLECULAR THERAPIES FOR HEPATOCELLULAR CARCINOMA (SPRINGER INTERNATIONAL PUBLISHING AG), pp. 25-43

2016

  1. Natural history of nonalcoholic steatohepatitis/nonalcoholic fatty liver disease-hepatocellular carcinoma: Magnitude of the problem from a hepatology clinic perspective

    Clinical Liver Disease, Vol. 8, Núm. 4, pp. 100-104

2006

  1. Effect of adenovirus-mediated RNA interference on endogenous microRNAs in a mouse model of multidrug resistance protein 2 gene silencing

    Journal of Virology, Vol. 80, Núm. 24, pp. 12236-12247